HPV legislation in South Dakota

From SourceWatch
Jump to: navigation, search

Women in Government Ratings

Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" [1]:


POPULATION: 781,919


Incidence & Mortality (2008 Score / 2007 Score)

  • Cervical Cancer Incidence Rate: 4.4/100,000 (2/ 2)
  • Cervical Cancer Incidence Rate/Race: White: 5.2
  • Cervical Cancer Mortality Rate: 2.2/100,000 (1 / 1)
  • Cervical Cancer Mortality Rate/Race: White: 1.8, Black: 5.3


Screening (2008 Score / 2007 Score)

  • Cervical Cancer Screening Rate: 85.1% (1 / 2)
  • Cervical Cancer Screening Rate/Race: White: 85%, American Indian/Alaskan: 88.5%
  • % Uninsured/Unscreened: 25.2% (1 / 1)
  • Medicaid Coverage HPV Testing: Restricted (0 / 0)


Healthcare Access (2008 Score / 2007 Score)

  • Rate Uninsured Women: 14% (1 / 1)
  • % Low Income/Uninsured Women: 28%


Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 0)

  • There are no new screening requirements.

Task Forces (0 / 0)

  • There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (2 / 2)

  • HB 1061 created the HPV Vaccine Initiative to provide the HPV vaccine to any woman 11–18 years of age to help protect against the virus that causes cervical cancer at an estimated cost of $9,200,000 million; signed by Gov. Rounds.

HPV Vaccine Information Programs (0 / 0)

  • There is no HPV vaccine information activity.

Miscellaneous (0 / 0)

  • There is no new miscellaneous cervical cancer prevention activity.


Annual Ratings

  • 2008: Fair (8 out of 22 points)
  • 2007: Fair (7 out of 18 points)


Articles and resources

SourceWatch Resources

External links

References